MJ Pharma SRL
MJ Pharma reported total assets of 534,747 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
The score of MJ Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +130 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MJ Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 23 Aug 2022
MJ Pharma's financial analysis
- Solvency51.8%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MJ Pharma
MJ Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0755.612.578
- VAT number
- BE0755612578
- Peppol
- Registered · 0208:0755612578 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Oct 2020
- Registered office
- 2290 Vorselaar
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
MJ Pharma (SRL) has been based in Vorselaar since 2020, active in: activities of holding companies. For 2025, it reports a net profit of 61,088 € and equity of 277,228 €; its revenue is not published. Its solvency stands at 51.8%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to MJ Pharma
Companies in the same business, of comparable size and area, outside its group.
- NOMA'S Ventures Activities of holding companies Wervik · balance sheet 112,657 €
- AVP Consult Activities of holding companies Lichtervelde · balance sheet 602,890 €
- Bawser Activities of holding companies Niel · balance sheet 629,403 €
- L&L Investments Activities of holding companies De Panne · balance sheet 706,958 €
- LCON Activities of holding companies Jabbeke · balance sheet 383,498 €
- C&H Management Activities of holding companies Rixensart · balance sheet 754,575 €
- Hollanders Activities of holding companies Peer · balance sheet 378,462 €
- S.L. Activities of holding companies Poperinge · balance sheet 774,107 €
Frequently asked questions about MJ Pharma
What is the revenue of MJ Pharma?
MJ Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MJ Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0755612578 for MJ Pharma, if the company is VAT-registered. Its company number (CBE) is 0755.612.578.
Where is the registered office of MJ Pharma?
According to the CBE register, the registered office of MJ Pharma is in 2290 Vorselaar.
What is the equity of MJ Pharma?
At the close of the 2025 financial year, the equity of MJ Pharma amounts to 277,228 €, a solvency of 51.8% of total assets.
Who manages MJ Pharma?
The register lists 1 active mandates at MJ Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MJ Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →